Search results
- 11.75Add to watchlist-0.30 (-2.49%)At close: Thu. May 30, 2024 4:00 PM EDT · Delayed Quote (USD) · Market closed
- Open12.08High12.70Low11.62
- Mkt Cap12.15MP/E (TTM)N/ADiv & YieldN/A & N/A
- Prev. Close12.0552 Wk. Low3.9552 Wk. High1,130.40
Top storiesIs Avalo Therapeutics (AVTX) Stock Outpacing Its Medical Peers This Year?Yahoo Finance · 1 week agoRelated stocks
May 22, 2024 · AVTX Avalo Therapeutics, Inc. Stock Price & Overview. Follow. 3.52K followers. $10.79 -0.13 ( -1.19%) 3:59 PM 05/22/24. NASDAQ | $USD | Post-Market: $9.60 -1.19 (-11.03%) 7:59 PM. Summary....
May 23, 2024 · AVTX is a biotech company developing anti-inflammatory drugs. See its stock performance, valuation, financials, and industry comparables on Morningstar.com.
5 days ago · Stock analysis for Avalo Therapeutics Inc (AVTX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
- 19
4 days ago · Free AVTX Stock Alerts. $13.10. +1.95 (+17.49%) (As of 05/24/2024 ET) Compare. Share. Today's Range. $10.98. . $13.23. 50-Day Range. $4.35. . $21.75. 52-Week Range. $3.95. . $1,130.40. Volume. 44,830 shs. Average Volume. 54,215 shs. Market Capitalization. $13.49 million. P/E Ratio. N/A. Dividend Yield. N/A. Price Target. N/A. Stock Analysis.
- 540 Gaither Rd Ste 400, Rockville, Maryland 20850-6713
- ir@cerecor.com
- (410) 522-8707
- 19
People also ask
How volatile is Avalo Therapeutics (avtx) share price?
Where can I buy avtx stock?
Will AVT stock price drop/fall or rise?
Who owns avtx-800 series?
6 days ago · Avalo Therapeutics is a biotech company developing treatments for inflammatory and autoimmune diseases. See its latest stock price, earnings, news, financials, statistics, forecast and chart on Stock Analysis.
May 21, 2024 · Avalo Therapeutics, Inc. (AVTX.NASDAQ): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Avalo Therapeutics, Inc. | Nasdaq: AVTX | Nasdaq.
May 20, 2024 · 1Y. -98.5% Updated. 20 May, 2024. Data. Company Financials +. 1 Analyst. AVTX Stock Overview. A clinical stage biotechnology company, focuses on the development of therapies for the treatment of immune dysregulation in the Unites States. About the company. Rewards. Risk Analysis. Does not have a meaningful market cap ($10M)